About the Symposium
The 36th edition of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics will take place as an in-person event at the CCIB in Barcelona in October 2024.
ENA 2024 stands as the drug development and translational research meeting, giving the spotlight to preclinical and phase I studies, ensuring in-depth scientific discussions on the latest developments in targets and drugs.
Attracting an international audience of academics, scientists and pharmaceutical industry leaders, this event enables discussions on the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.
Programme
Key dates
Don’t want to miss any important key dates for ENA?
Plan ahead and add all the key dates for the conference into your diary.
Ensuring you don’t miss out on any deadlines.
Our speakers
With a truly wide ranging scientific programme, the ENA 2024 Symposium brings together over 60 top experts in all fields of drug development and translational research from Europe and around the world.
Chair ENA 2024
Co-Chair of AACR
Co-Chair of NCI